Key points are not available for this paper at this time.
Antiphospholipid antibodies can induce endothelial-cell, complement, platelet, neutrophil, and monocyte activation, leading to thrombosis, renal failure, heart valve disease, pregnancy loss, and neurologic complications. Warfarin is the main treatment option.
García et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: